Active ingredients: Calcipotriol 50 mcg/g and betamethasone dipropionate 0.5 mg/g (as betamethasone dipropionate 0.643 g/g)
Dosage form: Cutaneous foam
Pack size: 60 g canister (net weight 146.4 g / 268 ml)
Manufacturer: LEO Pharma
Route: Cutaneous use
Enstilar is a two-component dermal foam developed by LEO Pharma. It combines calcipotriol, a vitamin D3 analogue that normalizes skin cell maturation, with betamethasone dipropionate, a potent corticosteroid that reduces inflammation and itching.
The foam format allows easy application to both body and scalp and ensures even distribution without greasy residue.
Apply once daily to the affected skin areas. The canister should be shaken before use and held upright during application. The usual course is up to 4 weeks; further use is determined by the physician.
Maximum weekly dose should not exceed 15 g (up to 30 g under medical supervision per protocol). Wash hands after application.
Store upright at a temperature not exceeding 25 °C. Do not refrigerate. The canister is flammable: keep away from fire and do not puncture. Keep out of reach of children.
It is a topical foam for plaque psoriasis in adults, including scalp involvement.
Once daily to the affected areas. The usual course is up to 4 weeks; further use is decided by your doctor.
No. Avoid the face, mucous membranes and skin folds.
No. Enstilar is indicated for adults from 18 years.
Yes, it is a prescription-only medicine in most countries.
Ask a question or inquire about delivery to your country

